Pharmaceutical compositions or health care product having blood sugar reduction effect
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and a hypoglycemic technology are applied in the field of pharmaceutical compositions or health products, and in the field of hypoglycemic pharmaceutical compositions or health products to achieve the effect of taking safety
Inactive Publication Date: 2013-02-20
北京润康普瑞生物技术有限公司
View PDF4 Cites 6 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
There is a lack of a pharmaceutical composition or health product that starts from the source of improving insulin
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0058] Preparation of powder
[0059] Weigh each component: 260 parts of bitter melon extract, 290 parts of olive extract, 230 parts of cinnamon extract, 150 parts of guava extract, 140 parts of tartary buckwheat extract, 20 parts of astaxanthin, 20 parts of lutein , 10 parts of chromium-containing yeast, 2500 parts of xylitol.
[0060] Mix well, put it into a bag, and get it; the amount of each bag is 2.5g.
Embodiment 2
[0062] Preparation of granules
[0063] 320 parts of bitter melon extract, 400 parts of olive extract, 340 parts of cinnamon extract, 200 parts of guava extract, 200 parts of tartary buckwheat extract, 40 parts of astaxanthin, 25 parts of lutein, 13 parts of chromium-containing yeast, Xylitol 2800 parts.
[0064] Mix the above-mentioned components evenly, make granules, pack, and obtain, and the amount of each bag is 2.5g.
Embodiment 3
[0066] Preparation of granules
[0067] Weigh each component: 380 parts of bitter melon extract, 450 parts of olive extract, 380 parts of cinnamon extract, 245 parts of guava extract, 220 parts of tartary buckwheat extract, 50 parts of astaxanthin, 33 parts of lutein, 17 parts of chromium-containing yeast and 3000 parts of xylitol.
[0068] Mix the above-mentioned components evenly, make granules, pack, and obtain, and the amount of each bag is 2.5g.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a pharmaceutical composition or health care product having a blood sugar reduction effect. The pharmaceutical composition contains the following components in parts by weight: 260-520 parts of momordica charantia extract, 290-600 parts of olive extract, 230-540 parts of cinnamon extract, 150-280 parts of guava extract, 140-310 parts of tartary buckwheat extract, 20-80 parts of astaxanthin, 20-40 parts of lutein, 10-25 parts of chromium-containing yeast, and 2500-3800 parts of xylitol. After being added with auxiliary materials or carries required for preparation forming, the pharmaceutical composition disclosed by the invention can be prepared into any suitable pharmaceutical preparation acceptable clinically according to a conventional preparation method in the field. Proved by pharmacology test result, the pharmaceutical composition or health care product has good effect of reducing blood sugar, has no toxic or side effect on animals, and is safe to take.
Description
technical field [0001] The invention relates to a pharmaceutical composition or a health product, in particular to a pharmaceutical composition or a health product with the function of lowering blood sugar, and belongs to the field of a blood sugar lowering pharmaceutical composition or health product. Background technique [0002] Diabetes mellitus is a metabolic disease characterized by elevated blood sugar caused by defects in insulin secretion and (or) action. It is a comprehensive chronic disease mainly characterized by disorders of glucose metabolism. Diabetic patients with long-term poor blood sugar control may be accompanied by various organs, especially eye, heart, blood vessel, kidney, nerve damage or organ insufficiency or failure, resulting in disability or premature death. [0003] In recent years, with the development of social economy and the improvement of residents' living standards in all countries in the world, the incidence and prevalence of diabetes have...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more